Levofloxacin Lactate forms the cornerstone of several pharmaceutical compounds, standing out among fluoroquinolone antibiotics for its robust antibacterial activity. Its molecular structure combines the broad-spectrum antibiotic levofloxacin with lactic acid, resulting in improved solubility compared to the base drug. The compound carries the chemical formula C18H20FN3O6, sporting a molecular weight of approximately 393.4 g/mol. Its refinement and purity levels set the stage for both hospital environments and raw material supply chains. Hospitals rely on it to address bacterial infections resistant to many other options, and producers choose it for its consistent performance in compounding.
Levofloxacin Lactate often appears as a white to off-white solid in pharmaceutical settings, ranging from fine powder to crystalline flakes or pearls, depending on the manufacture. The physical form brings advantages: powder permits easy measurement, while pearl or flake options improve storage and handling in industrial-scale production. Its solid state boasts a specific density, typically around 1.35 g/cm³, and dissolves in water to create clear, colorless to pale yellow solutions, which is a crucial trait during formulation. Sharp attention to hygroscopicity matters—producers must shield the compound from moisture to guarantee stability, since even small water uptake can alter its reactivity and batch consistency. For those in the industry, these traits directly affect shelf life, blending actions, and effectiveness in the field.
As a derivative of levofloxacin, the compound features a distinctive fluorine atom and a substituted piperazine ring, which sharpen its antimicrobial reach. The lactate piece helps it move smoothly through aqueous solutions, making the drug easier to administer intravenously or to manipulate during formulation. The international trade environment classifies Levofloxacin Lactate under the HS Code 29419090, which covers a spectrum of heterocyclic compounds with nitrogen hetero-atoms, a fitting home since its structure is key to its mode of action. This HS Code supports customs processing and documentation, acting as a recognized marker for global commerce. The complexity of the molecular architecture makes it ideal for high-stakes environments such as hospitals, but also asks for extra scrutiny regarding storage and shipping—the smallest regulatory slip can lead to costly delays or compliance risk.
Bulk suppliers typically offer Levofloxacin Lactate as powder with fine particle size for easy weighing and dissolution. Crystal and flake versions cater to facilities focused on longevity during storage, as these forms often resist caking, clumping, or unintended chemical reactions. When dissolved, technicians usually work with solutions ranging from 50 mg/mL to 100 mg/mL concentrations, tailored for end-use demands. Each batch undergoes strict quality testing for purity (greater than 98%), water content, heavy metal content, and residual solvents. These controls matter to buyers, since any deviation can affect downstream product safety and reliability. Stability under different temperature and humidity settings remains a topic of everyday concern. Refrigerated storage (2-8°C) with protection from light usually safeguards the powder, while sealed amber bottles help prevent degradation of liquid forms during transit or use.
Levofloxacin Lactate demands disciplined attention to safety protocols, since exposure can trigger harmful effects if mismanaged. Direct contact with skin or eyes prompts irritation; improper inhalation of dust or powder can damage respiratory passages. Workers handle this compound in settings equipped with gloves, goggles, and certified dust extraction systems to keep ambient concentrations below acceptable exposure limits. Spill management follows strict chemical hygiene plans, with authorized personnel clearing and discarding waste through licensed hazardous disposal systems. On the consumer side, levofloxacin lactate-based medicines come with clear dosing and warning information, helping patients avoid overexposure which could result in joint pain, gastrointestinal distress, or nerve issues. These safety conversations echo in every manufacturing or storage facility because patient and worker health hinge on responsible material stewardship.
Anyone involved in the production or handling of Levofloxacin Lactate recognizes its double-edged nature—key therapeutic action balanced by real risks. Oral or intravenous misuse can provoke severe hypersensitivity, tendon rupture, or cardiac effects in vulnerable groups. Industry must answer to local and international chemical safety directives (such as REACH in Europe, or OSHA in the U.S.), which spell out guidelines for labeling, exposure monitoring, and emergency response. Safe storage goes beyond low temperature and darkness: containers must remain airtight, properly labeled, and trackable in digital inventory systems. This discipline proves its worth during regulatory audits, where the ability to trace each batch back to raw materials, manufacturer lots, and shipping documents stands between a company and steep fines—or product recalls.
Raw materials for levofloxacin lactate production often include levofloxacin base, lactic acid, purified water, and stabilizers or pH adjusters. Sourcing these inputs calls for global reach: top-rated suppliers guarantee consistent quality, batch certification, and documentation for every kilogram delivered. Shipping standards stay strict, with sealed drums or multi-layered packaging to hold back moisture and chemical contaminants. Full transparency from source to shelf keeps downstream customers—pharmaceutical manufacturers, distributors, or clinics—confident in their final product. Gaps in the supply chain can translate to medicine shortages or quality failures. By maintaining tight supplier audits, regular lab testing, and clear documentation, industry players keep trust intact, uphold compliance, and ensure that every gram meets the rigorous standards demanded by modern healthcare and regulation.
